Pharma & Biotech
FSD Pharma is building a mammoth hydroponic indoor cannabis production and processing facility
Australis Capital poised to take advantage of the rapidly growing US cannabis market
Seelos Therapeutics has catalysts for its ketamine depression drug, multiple shots on goal with a strong pipeline
Only registered members can use this feature.
Copyright © Proactive Investors 2019.
All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC.